Rung Five

The colorectal cancer pathway, step by step

Colorectal cancer is one of the few cancers screening can prevent, by removing polyps before they turn into cancer. It is rising in younger adults, so screening now starts at 45.

Step 1: Start screening at 45, with a test you’ll actually do

The U.S. Task Force and the American Cancer Society both say to start at 45 and continue to 75. The Task Force calls screening from 76 to 85 an individual decision; the American Cancer Society says to stop after 85. Recommended options are a FIT or guaiac stool test every year, a stool DNA or RNA test every 3 years, CT colonography or flexible sigmoidoscopy every 5 years, or colonoscopy every 10 years. The best test is the one you complete. Blood tests are a fallback for people who won’t do any of these.

24–28colorectal cancer deaths prevented for every 1,000 people screened from 45 to 75U.S. Task Force modeling, 2021
About 1 in 3eligible U.S. adults aren’t up to date with screeningAmerican Cancer Society, May 2026
19%fewer colorectal cancers in people invited to one colonoscopy, after 13 yearsNordICC, 84,583 people

Rated options for this step

Sources for this step (5)

Step 2: A positive stool or blood test means a colonoscopy

A positive result isn’t a diagnosis, but it needs a follow-up colonoscopy, preferably within 6 months, says the American Cancer Society. A stool or blood test only helps if that follow-up happens. Colonoscopy after a positive stool test carries slightly higher risks than a screening colonoscopy: about 17.5 serious bleeds and 5.4 bowel tears per 10,000 procedures, according to the U.S. Task Force review.

Within 6 monthsthe recommended time to have a colonoscopy after a positive stool or blood testAmerican Cancer Society, May 2026
Sources for this step (2)

Step 3: Check your family history

Having a parent, sibling or child with colorectal cancer doubles your risk, according to the National Cancer Institute. Inherited conditions such as Lynch syndrome and familial adenomatous polyposis (FAP) raise it much further and mean colonoscopy from a much younger age. If you have Lynch syndrome, ask your genetics team about aspirin: in one long trial it about halved colorectal cancers, but it carries bleeding risks.

2 timesthe risk if a parent, sibling or child had colorectal cancerNational Cancer Institute
10% to 80%lifetime colorectal cancer risk with Lynch syndrome, depending on the geneAmerican Cancer Society
40 vs 58colorectal cancers with aspirin vs placebo in 861 people with Lynch syndrome, over 10 to 20 yearsCAPP2, Lancet 2020

Rated options for this step

Sources for this step (3)

Step 4: Lower your risk

The biggest steps are the ones that lower the risk of many cancers: don’t smoke, drink less alcohol or none, keep a healthy weight and move most days. For colorectal cancer specifically, processed meat is a known cause and red meat probably raises risk, while whole grains and fiber probably lower it. Daily aspirin isn’t recommended for prevention for most people, and calcium pills haven’t been shown to prevent polyps.

Skip colon cleanses and coffee enemas: no evidence of benefit, and real harms.

Rated options for this step

Sources for this step (8)

Step 5: If diagnosed: test the tumor, then treat

Surgery is the main treatment for colon cancer, often followed by chemotherapy for stage III; for many lower-risk stage III cancers, three months of chemotherapy works as well as six. Rectal cancer is often treated with chemotherapy and radiation before surgery, and some people can be monitored instead of having surgery after a strong response.

Every tumor should be tested for mismatch-repair deficiency. Since 2025, immunotherapy has been approved for these tumors when the cancer has spread, after surgery for stage III colon cancer, and in place of surgery for some rectal cancers. For cancer that has spread, tumor gene results such as BRAF guide targeted drugs.

Apr 8, 2025Nivolumab with ipilimumab approved for advanced MSI-H or dMMR colorectal cancerFDA
Oct 8, 2026Atezolizumab with chemotherapy approved after surgery for stage III dMMR colon cancerFDA
Oct 19, 2026Dostarlimab given accelerated approval for stage II–III dMMR rectal cancerFDA
30.3 vs 15.1months of median survival with BRAF-targeted treatment vs standard chemotherapyBREAKWATER, FDA, Feb 2026

Rated options for this step

Sources for this step (8)

Step 6: After treatment: exercise is the best-proven step

In the CHALLENGE trial, 889 people who had finished chemotherapy for colon cancer were assigned to a three-year coached exercise program or to health education materials. The exercise group had a 28% lower risk of the cancer coming back or a new cancer, and a 37% lower risk of death. The American Cancer Society’s guideline for survivors also links being active to better survival, and a Western-style diet to worse survival. For tumors with PI3K-pathway changes, low-dose aspirin after surgery lowered recurrence in a randomized trial; it carries a safety flag, so decide with your oncologist.

37%lower risk of death with a three-year coached exercise program after colon cancerCHALLENGE, 889 patients

Rated options for this step

Sources for this step (3)

Everything rated for colorectal cancer

All 32 options that apply to colorectal cancer, including options rated 4 or 5 that apply to every cancer, grouped by how strong the evidence is.

5

Rung 5 · Established

Large randomized trials or overwhelming, consistent human evidence; reflected in major guidelines11 options
4

Rung 4 · Strong

At least one large randomized trial, or very large consistent studies, on this exact question13 options
3

Rung 3 · Moderate

Consistent observational studies or small trials, not yet confirmed by large trials4 options
2

Rung 2 · Limited

Few, small or conflicting human studies, or only indirect measures such as blood markers4 options
Filter every option in the evidence register